Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Antibe Therapeutics Inc(Pre-Merger) ATBPF

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug,... see more

GREY:ATBPF - Post Discussion

View:
Post by Forestview on Jun 03, 2021 9:45am

MC Cap the same

Weird that this has closed, and there is no change to the Market Cap as a result of the amalgamation?  That should have increased to reflect the patents, and the share count should have increased to reflect Holdings.  Am I missing something?
Comment by GameChangerBet on Jun 03, 2021 9:53am
Takes a day or so to update in the stats
Comment by Forestview on Jun 03, 2021 10:17am
Ah ok.  I don't think this will takeoff until the numbers are fully baked in.  Hopefully Monday will be the start of a new era. Interestingly enough, we've passed the anniversary of the Phase 2 results.  Our 52 week high will consistently drop over the next few weeks reflecting last years bought deal and impact.  
Comment by 123ABC on Jun 03, 2021 10:43am
Lower your expectations it'll save you from continue disappointment.
Comment by GameChangerBet on Jun 03, 2021 10:54am
Raise your intelligence, it'll save us from annoyance
Comment by 123ABC on Jun 03, 2021 11:04am
Hey man, hit that ignore button, you're choosing to see my posts
Comment by MrMugsy on Jun 03, 2021 11:19am
Right !  I year since P2B results were posted. Now we wait for a catalyst - hoping the amalgamation takes negotiations to the next level. Based on the China deal alone, I would expect a minimum of ... $529M from a USA partner $176M from a European partner $83.5M from a Japan partner. A Japan deal could be higher if it covers additional geographies. So ... $789M in milestone ...more  
Comment by GameChangerBet on Jun 03, 2021 11:29am
From my understanding in talks with the company, discussions with US/Europe pharma's should now be completed, at least in terms of initial contact, with Japan being next. And by extension, a deal can take place at any time, however it would be wise to be cognizant of the fact that it may take some time. During last Summer and Fall the concentration was China and a deal was announced in Feb ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities